Skip to content
akaturk Academic measurement
Sign in Register

OpenAlex topic

Inflammatory Biomarkers in Disease Prognosis

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 8,989 works 415 author topics

Works

8,989 works

  1. Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study 2020
    OpenAlex top 1% OpenAlex 99.8%

    PURPOSE Pembrolizumab monotherapy has shown antitumor activity in patients with small-cell lung cancer (SCLC). The randomized, double-blind, phase III KEYNOTE-604 study compared pembrolizumab plus etoposide and platinum (EP) with placebo plus EP for patients with previously untreated extensive-stage (ES) SCLC. METHODS…

  2. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. 1995
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.2%

    PURPOSE: To analyze factors that affect the collection of peripheral-blood stem cells (PBSC) before transplant and the tempo of engraftment after transplant. PATIENTS AND METHODS: A consecutive series of 243 patients with breast cancer (n = 87), malignant lymphoma (n = 90), multiple myeloma (n = 32), or other malignan…

  3. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. 1995
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.2%

    PURPOSE: To analyze factors that affect the collection of peripheral-blood stem cells (PBSC) before transplant and the tempo of engraftment after transplant. PATIENTS AND METHODS: A consecutive series of 243 patients with breast cancer (n = 87), malignant lymphoma (n = 90), multiple myeloma (n = 32), or other malignan…

  4. The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma 2008
    OpenAlex top 10% OpenAlex 92.0%

    No abstract yet.

  5. Mean platelet volume MPV as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 94.3%

    No abstract yet.

  6. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 94.3%

    No abstract yet.

  7. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 94.3%

    No abstract yet.

  8. Mean platelet volume MPV as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 94.3%

    No abstract yet.

  9. The Influence of Nutritional Status on Complications after Major Intraabdominal Surgery 2004
    OpenAlex top 10% OpenAlex 90.5%

    OBJECTIVE: Currently most nutritional assessment techniques are based on their ability to predict clinical outcomes. However, the validity of any of these techniques to truly measure "nutritional risk" has not been proved. We have therefore prospectively assessed the prognostic value of two nutritional assessment tech…

  10. Mean platelet volume in Type 2 diabetic patients 2004
    YÖKSİS SJR Q1 JCR Q3 OpenAlex top 10% OpenAlex 93.2%

    No abstract yet.

  11. Platelet to lymphocyte ratio better predicts inflammation than neutrophil to lymphocyte ratio in end stage renal disease patients 2013
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 98.6%

    Neutrophil-to-lymphocyte ratio (NLR) was introduced as a potential marker to determine inflammation in end-stage renal disease (ESRD) patients. Recently, platelet-to-lymphocyte ratio (PLR) and NLR were found to positively correlated with inflammatory markers including tumor necrosis factor-α (TNF-α) and interleukin (I…

  12. Platelet to lymphocyte ratio better predicts inflammation than neutrophil to lymphocyte ratio in end stage renal disease patients 2013
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 98.6%

    Neutrophil-to-lymphocyte ratio (NLR) was introduced as a potential marker to determine inflammation in end-stage renal disease (ESRD) patients. Recently, platelet-to-lymphocyte ratio (PLR) and NLR were found to positively correlated with inflammatory markers including tumor necrosis factor-α (TNF-α) and interleukin (I…

Academicians

415 academicians